February 15, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces it was notified on February 12, 2016, that Steven Gillis, Non-Executive Director of the Company, acquired 310 American Depositary Shares (“ADSs”) at an average price of $154.7699 per ADS. The transaction took place on February 12, 2016, on the NASDAQ Global Select Market. One ADS is equal to three Ordinary Shares of 5 pence each in the Company.
This notification is to satisfy the Company’s obligations under 3.1.4(R)(1)(a) of the Disclosure Rules and Transparency Rules.
Senior Assistant Company Secretary
|[email protected]||+1 781 482 9502|
|[email protected]||+44 1256 894157|
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.